NASDAQ | DRNA

$3.04 + 0.10 (+3.401%)

3 month stock price graph

4:00 PM ET on Dec 2, 2016 Pricing delayed 20 minutes

Investors & Media

Investors & Media

Dicerna is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare, inherited diseases involving the liver and for cancers that are genetically defined. The Company is using its proprietary RNA interference (RNAi) technology platform to build a broad pipeline in these therapeutic areas.

Latest Events

Nov 16, 2016

Stifel 2016 Healthcare Conference

Nov 7, 2016 at 4:30 PM ET

Q3 2016 Earnings Conference Call